Literature DB >> 21506635

ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.

Karin Lövgren Bengtsson, Bror Morein, Albert Dme Osterhaus.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21506635     DOI： 10.1586/erv.11.25

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  44 in total

Review 1.  Adjuvants for human vaccines.

Authors:  Carl R Alving; Kristina K Peachman; Mangala Rao; Steven G Reed
Journal:  Curr Opin Immunol       Date:  2012-04-19       Impact factor: 7.486

2.  Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.

Authors:  Jenna Anderson; Emmanuel Bréard; Karin Lövgren Bengtsson; Kjell-Olov Grönvik; Stéphan Zientara; Jean-Francois Valarcher; Sara Hägglund
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

3.  Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.

Authors:  A F Altenburg; S E Magnusson; F Bosman; L Stertman; R D de Vries; G F Rimmelzwaan
Journal:  Clin Exp Immunol       Date:  2017-07-24       Impact factor: 4.330

Review 4.  Ebola virus disease candidate vaccines under evaluation in clinical trials.

Authors:  Karen A Martins; Peter B Jahrling; Sina Bavari; Jens H Kuhn
Journal:  Expert Rev Vaccines       Date:  2016-05-27       Impact factor: 5.217

5.  Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimer.

Authors:  Joseph P Nkolola; Ann Cheung; James R Perry; Darrick Carter; Steve Reed; Hanneke Schuitemaker; Maria Grazia Pau; Michael S Seaman; Bing Chen; Dan H Barouch
Journal:  Vaccine       Date:  2014-02-18       Impact factor: 3.641

6.  An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.

Authors:  Mojca Skoberne; Rhonda Cardin; Alexander Lee; Ana Kazimirova; Veronica Zielinski; Danielle Garvie; Amy Lundberg; Shane Larson; Fernando J Bravo; David I Bernstein; Jessica B Flechtner; Deborah Long
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

7.  Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants.

Authors:  Robyn Marty-Roix; Gregory I Vladimer; Kimberly Pouliot; Dan Weng; Rachel Buglione-Corbett; Kim West; John D MacMicking; Jonathan D Chee; Shixia Wang; Shan Lu; Egil Lien
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

Review 8.  Advances of nanomaterials-based strategies for fighting against COVID-19.

Authors:  Chunxi Zeng; Xucheng Hou; Margaret Bohmer; Yizhou Dong
Journal:  View (Beijing)       Date:  2021-05-05

9.  Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.

Authors:  Jenny M Reimer; Karin H Karlsson; Karin Lövgren-Bengtsson; Sofia E Magnusson; Alexis Fuentes; Linda Stertman
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Controlling the HIV/AIDS epidemic: current status and global challenges.

Authors:  Thorsten Demberg; Marjorie Robert-Guroff
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.